Ads
related to: is anywhere treating pulmonary fibrosis due to radiation treatment side effects- Finding Support
Provide Patients With Access To
Their Own Personalized Care.
- Treatment Efficacy
Learn About The Clinical Trial
Results Before Prescribing.
- Finding Support
Search results
Results from the WOW.Com Content Network
Pulmonary fibrosis is not currently curable; but some steps can be taken to minimize its effects, such as changing the treatment regimen. Other measures that should be taken into account are quitting smoking (if applicable), oxygen therapy, pulmonary rehabilitation, vaccination against influenza and pneumococcus to prevent lung infections, or in extreme cases, a lung transplant.
Radiation-induced lung injury (RILI) is a general term for damage to the lungs as a result of exposure to ionizing radiation. [1] In general terms, such damage is divided into early inflammatory damage ( radiation pneumonitis ) and later complications of chronic scarring ( radiation fibrosis ).
Pulmonary toxicity is the medical name for side effects on the lungs. Although most cases of pulmonary toxicity in medicine are due to side effects of medicinal drugs, many cases can be due to side effects of radiation (radiotherapy). Other (non-medical) causes of pulmonary toxicity can be chemical compounds and airborne particulate matter.
Treatment options for idiopathic pulmonary fibrosis are very limited, since no current treatment has stopped the progression of the disease. Because of this, there is no evidence that any medication can significantly help this condition, despite ongoing research trials.
The most important factor for treating DAD or ARDS is to treat the underlying cause of the injury to the lungs, [9] for example pneumonia or sepsis. These patients will have problems with oxygenation, meaning they will likely need a breathing tube , medications to keep them comfortable (sedative, paralytic, and/or analgesic), and a mechanical ...
[38] [39] It is the first FDA-approved treatment for this rare lung condition. [38] The effectiveness of nintedanib to treat SSc-ILD was studied in a randomized, double-blind, placebo-controlled trial of 576 subjects ages 20–79 with the disease. [38] Subjects received treatment for 52 weeks, with some subjects treated up to 100 weeks. [38]
Ads
related to: is anywhere treating pulmonary fibrosis due to radiation treatment side effects